Consensus document on the progression and treatment response criteria in gastroenteropancreatic neuroendocrine tumors

Authors:

Abstract
Gastroenteropancreatic neuroendocrine tumors are a heterogeneous group of low incidence neoplasms characterized by a low proliferative activity and slow growth. Their response to targeted therapies is heterogeneous and often does not lead to tumor shrinkage. Thus, evaluation of the therapeutic response should differ from other kind of tumors.
Funding Information
  • Novartis

This publication has 30 references indexed in Scilit: